R. Giger

发表

The serotonin 5-HT4 receptor. 2. Structure-activity studies of the indole carbazimidamide class of agonists.

K. Buchheit, D. Hoyer, H. Pfannkuche, 1995, Journal of medicinal chemistry.

Synthesis of potential drug metabolites by a modified Udenfriend reaction

J. Peters, R. Slavik, R. Giger, 2011 .

Pharmacological profile of the abeorphine 201-678, a potent orally active and long lasting dopamine agonist.

A. Jaton, A. Enz, R. Markstein, 1986, Life sciences.

Design and synthesis of a transition state analog of a metalloporphyrin-catalysed oxidation reaction

P. Hoffmann, R. Giger, 2002 .

A new semisynthetic ergot peptide alkaloid: DCN 203-922

M. Walkinshaw, H. Loosli, R. Giger, 1987, Experientia.

Chapter 13 Case History on Tegaserod (Zelnorm®/Zelmac®)

H. Pfannkuche, H. Mattes, R. Giger, 2007 .

Albert Hofmann's Pioneering Work on Ergot Alkaloids and Its Impact on the Search of Novel Drugs at Sandoz, a Predecessor Company of Novartis: Dedicated to Dr. Albert Hofmann on the occasion of his 100th birthday

G. Engel, R. Giger, 2006 .

High affinity of SDZ HTF-919 related molecules for calf and human caudate 5-HT4 receptors.

D. Hoyer, A. Probst, H. Mattes, 1998, Annals of the New York Academy of Sciences.

The serotonin 5-HT4 receptor. 1. Design of a new class of agonists and receptor map of the agonist recognition site.

K. Buchheit, D. Hoyer, H. Pfannkuche, 1995, Journal of medicinal chemistry.

Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection.

Peter Meier, Pierre Acklin, Kamal Azzaoui, 2005, Current topics in medicinal chemistry.